Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early prophylactic CD4-positive donor lymphocyte infusion after T-cell depleted unrelated allogeneic stem cell transplantation
NL-OMON20464Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2012
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of CD4-positive donor lymphocytes in hematopoietic malignancies (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Circulating naive CD4-positive lymphocyte count. Started Sep 2012; status: recruiting.
02
Drugs
CD4-positive donor lymphocytes
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on NL-OMON20464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20464.